IndieBio

IndieBio is a prominent deep tech and life sciences accelerator and venture capital firm, operating as a core program within SOSV, a global venture capital firm. Founded in 2014 by Arvind Gupta, IndieBio was established to provide pre-seed investment and hands-on support to scientists and entrepreneurs aiming to build breakthrough companies in biotechnology. The firm focuses on addressing significant challenges in human and planetary health, fostering innovations across a broad spectrum of deep tech.

The accelerator program is intensive, typically lasting around four months, and offers startups initial funding, extensive lab facilities, expert mentorship, and a vast network of investors and industry professionals. IndieBio provides investments ranging from $250,000 to $525,000 in exchange for an 8-10% equity stake, with additional funding opportunities through initiatives like the Genesis Consortium. Its structured curriculum guides founders through scientific research, product development, regulatory strategy, and go-to-market planning, accelerating their journey from concept to viable product.

IndieBio has made hundreds of investments in companies across various sectors, including food, agriculture, industrial decarbonization, AI, therapeutics, diagnostics, materials science, and advanced therapeutics. Notable portfolio companies include Upside Foods, Perfect Day, and NotCo. The firm's leadership team, including partners like Po Bronson, Pae Wu, and Alex Kopelyan, brings diverse expertise in science, engineering, operations, and investment, working closely with founders to overcome operational challenges and secure follow-on funding. As of early 2026, IndieBio's operations in San Francisco and New York have been rebranded as SOSV SF and SOSV NY, reflecting SOSV's expanded focus beyond pure biology to encompass all areas of deep tech.